Tag: Chai Discovery
Chai Discovery scores BMS pact for AI-built antibodies
Chai Discovery adds Bristol Myers Squibb to its pharma roster for AI-built therapeutic antibodies.
Chai Discovery raises $400 million Series C for AI drug design
The startup behind AI molecule models used by Lilly, Novartis and Pfizer hits a $3.8 billion valuation.
Chai Discovery raises $400M at $3.8B valuation for AI drug design
The AI biotech startup triples its valuation in eight months with backing from Lilly, Pfizer and Novartis partnerships.